通过选择性胺基抑制剂探索活性位点循环动态对PTP1B/SHP2活性的影响
Qing Cao1, Tian-Tian Zhao1, Chun Zhang1
1School of Life Sciences and Health Engineering, Jiangnan University, Jiangsu, China.
Journal of biomolecular structure & dynamics
|January 13, 2026
概括
设计特定的蛋白氨酸酸酶1B (PTP1B) 抑制剂对于治疗癌症和糖尿病等疾病至关重要. 这项研究确定了WPD循环关闭是PTP1B选择性的关键,导致具有增强活性和减少副作用的新型抑制剂.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 蛋白氨酸酸酶1B (PTP1B) 是癌症,糖尿病和自身免疫性疾病的治疗点.
- 现有的PTP1B抑制剂通常向同源蛋白SHP2,导致潜在的毒性.
- 开发选择性PTP1B抑制剂需要了解作用的分子机制.
研究的目的:
- 阐明控制 PTP1B 和 SHP2 活动的分子机制.
- 设计具有高特异性和活性的新型PTP1B抑制剂.
- 确定增强抑制剂选择性的关键相互作用.
主要方法:
- 分子动力学模拟用于分析PTP1B/SHP2相互作用.
- 确定WPD循环关闭是酶活性的一个关键因素.
- 基于模拟发现的新型PTP1B抑制剂 (Q1) 的设计和合成.
主要成果:
- 确定WPD循环的闭合程度是PTP1B/SHP2活动的关键决定因素.
- 特定的相互作用,包括R47和抑制剂之间的键和π-相互作用,影响WPD循环的闭合.
- 设计的抑制剂Q1对PTP1B对SHP2的选择性超过20倍,对PTP1B的IC50为2.45μM.
结论:
- WPD循环关闭是实现PTP1B选择性的关键因素.
- 分子动力学模拟可以预测抑制剂的选择性和活性.
- 开发的战略为设计选择性PTP1B抑制剂提供了一种新方法.
相关概念视频
Enzyme Inhibition
91.5K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.5K
Allosteric Proteins-ATCase
6.5K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.5K
ATP Synthase: Mechanism
16.7K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
16.7K
Ligand Binding and Linkage
5.5K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.5K
Enzymes
93.8K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
93.8K
Allosteric Regulation
62.9K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
62.9K


